Skip to content

Comparison of EMR-P With Conventional EMR

Comparison of Precutting vs Conventional Endoscopic Mucosal Resection of Intermediate-Size Colorectal Polyps

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04191473
Enrollment
220
Registered
2019-12-09
Start date
2020-05-01
Completion date
2020-12-31
Last updated
2020-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp

Brief summary

Colorectal cancer is the third most common cancer in men and the second most common cancer in women.There are about 14 million cases of colonoscopy in the United States every year. In recent years, the incidence of colorectal cancer in China has risen sharply, becoming a serious threat to people's health.For small(≤ 9mm) lesions, endoscopic biopsy forceps and cold snare polypectomy can be used to remove.For larger lesions, especially laterally spreading tumor,endoscopic mucosal resection is a classic method of treatment.With the increasing diameter of the lesion size(\> 20mm),we also need to adopt endoscopic piecemeal mucosal resection or endoscopic submucosal dissection. As IT, Hook knife, BB, and other devices appear constantly, foreign researchers recently adopted a variation of conventional EMR(CEMR), namely endoscopic mucosal resection with circumferential precutting(EMR - P).The technology is superior to conventional EMR for 10 to 20 mm polyps.Moreover, preliminary studies suggest that it has good safety and efficacy, and may be a better method for treatment of 10-20mm polyps under colonoscopy. This clinical trial is being conducted to compare the efficacy and safety of two methods of polypectomy, CEMR and EMR-P, for 10-20mm colorectal polyps.

Interventions

PROCEDUREEMR-P

After submucosal injection, we use ESD knife or the tip of the entrapment device to loop around the lesion, and then overlapped the loop tangent with the entrapment device. After tightening the entrapment device, all the tumor tissues were confirmed to enter the entrapment device, and the tissues were removed.

PROCEDURECEMR

A liquid pad was formed by injecting 0.9% normal saline with meilan solution into submucosa,and then overlapped the loop tangent with the entrapment device. After tightening the entrapment device, all the tumor tissues were confirmed to enter the entrapment device, and the tissues were removed.

Sponsors

First Affiliated Hospital of Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* One polyp or lesion of 10-20mm at the most proximal of colorectal * Adult patients (≥18 years old) * Polyps other than pedicled polyps

Exclusion criteria

* There was submucosal infiltration under endoscope * Residual lesions after endoscopic resection * Inflammatory bowel disease, familial polyps, electrolyte abnormalities, coagulation disorders, or severe organ failure * Pregnant or nursing * No informed consent has been signed * Patients taking NSAIDs or other anticoagulants * sedated colonoscopy

Design outcomes

Primary

MeasureTime frameDescription
R0 rate7 daysen bloc resection with a histologically confirmed negative resection margin
En bloc rateimmediatelyendoscopically assessed removal of the lesion in one piece

Countries

China

Contacts

Primary ContactChaohui Yu, PhD
ych623@sina.com+8613957161659

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026